Skyworks Reports Q2 Fiscal 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Strong AI earnings lift S&P 500, Nasdaq as inflation data calms rate-hike jitters
- Oil prices little changed as investors weigh lower demand against US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
CFRA Downgrades Skyworks Solutions (SWKS) to Sell
May 8, 2025 2:02 PM EDTCFRA analyst Angelo Zino downgraded Skyworks Solutions (NASDAQ: SWKS) from Hold to Sell with a price target of $61.00 (from $73.00).
The analyst comments "More than a month ahead of PDUFA (06/30), VSTM has received FDA approval for avutometinib (RAS/MEK clamp) + defactinib (FAKi) combo... More
Skyworks Solutions (SWKS) Tops Q2 EPS by 4c, Offers Guidance
May 7, 2025 4:07 PM EDTSkyworks Solutions (NASDAQ: SWKS) reported Q2 EPS of $1.24, $0.04 better than the analyst estimate of $1.20. Revenue for the quarter came in at $953 million versus the consensus estimate of $951.52 million.
GUIDANCE:
Skyworks Solutions sees Q3 2025 EPS of $1.24, versus the consensus of $1.05. Skyworks... More
